Others

Genomic Valley Biotech Ltd - Outcome of Board Meeting

| Updated on November 05, 2018 Published on November 05, 2018

Pursuant to the Regulation 30 and any other applicable regulations of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors at its meeting held on 05th November, 2018, has inter-alia, approved the Un-Audited Financial Results of the Company for the Quarter and Half Year ended 30th September, 2018.

Further pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Un-Audited Financial Results of the Company for the Quarter and Half Year ended 30th September, 2018.

We are also enclosing a copy of the Limited Review Report of the Statutory Auditors of the Company, as required under Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations, 2015.

The aforesaid Board Meeting commenced at 11:45 AM and concluded at 02:30 P.M.

Pdf Link: Genomic Valley Biotech Ltd - Outcome of Board Meeting

Source : BSE - www.bseindia.com

Published on November 05, 2018
This article is closed for comments.
Please Email the Editor